-
1
-
-
84857743319
-
Diagnosing the decline in pharmaceutical R&D efficiency
-
Scannell JW, Blanckley A, Boldon H, Warrington B. Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov. 2012;11(3):191-200.
-
(2012)
Nat Rev Drug Discov
, vol.11
, Issue.3
, pp. 191-200
-
-
Scannell, J.W.1
Blanckley, A.2
Boldon, H.3
Warrington, B.4
-
2
-
-
77649234756
-
How to improve R&D productivity: The pharmaceutical industry's grand challenge
-
Paul SM, Mytelka DS, Dunwiddie CT, et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat Rev Drug Discov. 2010;9(3):203-214.
-
(2010)
Nat Rev Drug Discov
, vol.9
, Issue.3
, pp. 203-214
-
-
Paul, S.M.1
Mytelka, D.S.2
Dunwiddie, C.T.3
-
3
-
-
36248966518
-
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
-
Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861-872.
-
(2007)
Cell
, vol.131
, Issue.5
, pp. 861-872
-
-
Takahashi, K.1
Tanabe, K.2
Ohnuki, M.3
-
4
-
-
84862907693
-
Production of de novo cardiomyocytes: Human pluripotent stem cell differentiation and direct reprogramming
-
Burridge PW, Keller G, Gold JD, Wu JC. Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell. 2012;10(1):16-28.
-
(2012)
Cell Stem Cell
, vol.10
, Issue.1
, pp. 16-28
-
-
Burridge, P.W.1
Keller, G.2
Gold, J.D.3
Wu, J.C.4
-
5
-
-
84877579534
-
Drug attrition during pre-clinical and clinical development: Understanding and managing drug-induced cardiotoxicity
-
Ferri N, Siegl P, Corsini A, Herrmann J, Lerman A, Benghozi R. Drug attrition during pre-clinical and clinical development: understanding and managing drug-induced cardiotoxicity. Pharmacol Ther. 2013;138(3):470-484.
-
(2013)
Pharmacol Ther
, vol.138
, Issue.3
, pp. 470-484
-
-
Ferri, N.1
Siegl, P.2
Corsini, A.3
Herrmann, J.4
Lerman, A.5
Benghozi, R.6
-
6
-
-
84863116827
-
Dynamic monitoring of beating periodicity of stem cell-derived cardiomyocytes as a predictive tool for preclinical safety assessment
-
Abassi YA, Xi B, Li N, et al. Dynamic monitoring of beating periodicity of stem cell-derived cardiomyocytes as a predictive tool for preclinical safety assessment. Br J Pharmacol. 2012;165(5):1424-1441.
-
(2012)
Br J Pharmacol
, vol.165
, Issue.5
, pp. 1424-1441
-
-
Abassi, Y.A.1
Xi, B.2
Li, N.3
-
7
-
-
19644400578
-
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure
-
African-American Heart Failure Trial Investigators
-
Taylor AL, Ziesche S, Yancy C, et al African-American Heart Failure Trial Investigators. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med. 2004;351(20):2049-2057.
-
(2004)
N Engl J Med
, vol.351
, Issue.20
, pp. 2049-2057
-
-
Taylor, A.L.1
Ziesche, S.2
Yancy, C.3
-
8
-
-
84876526111
-
Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity
-
Liang P, Lan F, Lee AS, et al. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation. 2013;127(16):1677-1691.
-
(2013)
Circulation
, vol.127
, Issue.16
, pp. 1677-1691
-
-
Liang, P.1
Lan, F.2
Lee, A.S.3
|